[HTML][HTML] Crucial role of the transcription factors family activator protein 2 in cancer: current clue and views

C Jin, Y Luo, Z Liang, X Li, D Kołat, L Zhao… - Journal of Translational …, 2023 - Springer
The transcription factor family activator protein 2 (TFAP2) is vital for regulating both
embryonic and oncogenic development. The TFAP2 family consists of five DNA-binding …

The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers

D Kołat, Ż Kałuzińska, AK Bednarek… - Bioscience …, 2019 - portlandpress.com
Abstract The Activator Protein 2 (AP-2) transcription factor (TF) family is vital for the
regulation of gene expression during early development as well as carcinogenesis process …

[HTML][HTML] The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma

W Huang, Z Zhong, C Luo, Y Xiao, L Li, X Zhang… - Theranostics, 2019 - ncbi.nlm.nih.gov
Aberrant expression of transcription factor AP-2α has been functionally associated with
various cancers, but its clinical significance and molecular mechanisms in human glioma …

Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation

JAF Hannay, J Liu, QS Zhu, SV Bolshakov, L Li… - Molecular cancer …, 2007 - AACR
We investigated whether Rad51 overexpression plays a role in soft tissue sarcoma (STS)
chemoresistance as well as the regulatory mechanisms underlying its expression. The …

Activator protein‐2 in carcinogenesis with a special reference to breast cancer—a mini review

JM Pellikainen, VM Kosma - International journal of cancer, 2007 - Wiley Online Library
Abstract Activator protein‐2 (AP‐2) transcription factors are involved in the regulation of cell
proliferation, differentiation, apoptosis and carcinogenesis. AP‐2α has been suggested to …

[HTML][HTML] A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers

T Dunwell, L Hesson, TA Rauch, L Wang, RE Clark… - Molecular cancer, 2010 - Springer
Background Genetic as well as epigenetic alterations are a hallmark of both epithelial and
haematological malignancies. High throughput screens are required to identify epigenetic …

[HTML][HTML] A miR-200b/200c/429-binding site polymorphism in the 3′ untranslated region of the AP-2α gene is associated with cisplatin resistance

Y Wu, Y Xiao, X Ding, Y Zhuo, P Ren, C Zhou, J Zhou - PloS one, 2011 - journals.plos.org
The transcription factor AP-2α functions as a tumor suppressor by regulating various genes
that are involved in cell proliferation and apoptosis. Chemotherapeutic drugs including …

AP‐2α and AP‐2γ regulate tumor progression via specific genetic programs

F Orso, E Penna, D Cimino, E Astanina… - The FASEB …, 2008 - Wiley Online Library
The events occurring during tumor formation and progression display similarities to some of
the steps in embryonic morphogenesis. The family of AP‐2 proteins consists of five different …

Kahweol inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells

SH Oh, YP Hwang, JH Choi, SW Jin, GH Lee… - Food and Chemical …, 2018 - Elsevier
Kahweol is a coffee-specific diterpene found in the beans of Coffea arabica and has been
reported to demonstrate various biological activities, including anti-inflammatory …

Gelatinases-stimuli nanoparticles encapsulating 5-fluorouridine and 5-aza-2′-deoxycytidine enhance the sensitivity of gastric cancer cells to chemical therapeutics

F Wu, RT Li, M Yang, GF Yue, HY Wang, Q Liu, F Cui… - Cancer Letters, 2015 - Elsevier
Aberrant methylation of the transcription factor AP-2 epsilon (TFAP2E) has been attributed to
5-fluorouridine (5-FU) sensitivity. 5-Aza-2′-deoxycytidine (DAC), an epigenetic drug that …